Achievements & Reputation

Publication

60

Publication (WoS)

28

Publication (Scopus)

24

Citation (WoS)

840

H-Index (WoS)

12

Citation (Scopus)

952

H-Index (Scopus)

12

Citation (Scholar)

86

H-Index (Scholar)

2

Project

40

Thesis Advisory

12

Open Access

29
Congress and Symposium Activities 15
  • 01 November 2015 - 01 November 2015 Drug induced Liver Injury: Genomic Approaches and risk assassment- 25 november 2015

    Attendee

    İstanbul, Turkey

  • 01 April 2015 - 01 April 2015 International Symposium on Advances in Predictive & Personalized Medicine, İSTANBUL, TÜRKIYE, 2-3 Nisan 2015, pp.14-14

    Attendee

    İstanbul, Turkey

  • 01 May 2014 - 01 May 2014 14. Ulusal Kromatografi kongresi

    Attendee

    izmir, Turkey

  • 01 July 2013 - 01 July 2013 Proteomistanbul Uluslararası Katılımlı Yaz Okulu

    Attendee

    İstanbul, Turkey

  • 01 September 2010 - 01 September 2010 Investigation of association between paraoxonase-1 192/55 polymorphisms and serum paraoxonase activity in lung cancerSustainable Development

    Attendee

    İstanbul, Turkey

  • 01 December 2009 - 01 December 2009 Degredation mechanisms responsible for decreased levels of a neutral endopeptidase (NEP) variant allozyme

    Attendee

    San Diego, United States Of America

  • 01 May 2009 - 01 May 2009 Association of apurunic/apyrımıdınıc endonuclease (APE) gene polymorphisms with lung cancer in malesSustainable Development

    Attendee

    İstanbul, Turkey

  • 01 May 2009 - 01 May 2009 Investigation of MTHFR C677T gene polymorphism in patient with lung cancer.Sustainable Development

    Attendee

    İstanbul, Turkey

  • 01 March 2009 - 01 March 2009 Cytosolic, 5’-nucleotidase III (NT5C3) gene sequence variations and functional genomics

    Attendee

    Washington DC , United States Of America

  • 01 April 2008 - 01 April 2008 Gemcitabine pharmacogenomics: deoxycytidine kinase and cytidylate kinase gene resequencing and functional genomics

    Attendee

    Orlando, United States Of America

  • 01 April 2005 - 01 April 2005 Cyp1a1, Cyp2e1 Gene Polymorphisms, Smoking And Lung Cancer In Turkish PopulationSustainable Development

    Attendee

    İstanbul, Turkey

  • 01 May 2001 - 01 May 2001 Lung Cancer Risk in Relation to Dopamine 2 Receptor Gene (DRD2).Sustainable Development

    Attendee

    prag, Czech Republic

  • 01 May 2001 - 01 May 2001 NAD(P)H: Quinone Oxidoreductase Polymorphism and its Association to Lung Cancer in a Turkish PopulationSustainable Development

    Attendee

    prag, Czech Republic

  • 01 October 2000 - 01 October 2000 Identification of NAD(P)H: Quinone Oxidoreductase 609 C®T Polymorphism in a Turkish Population. XVIth National Congress of Biochemistry

    Attendee

    Selçuk, Turkey

  • 01 April 2000 - 01 April 2000 Dopamine D2 Receptor Gene (DRD2) Polymorphisms in a Turkish Population

    Attendee

    Antalya, Turkey